我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

索引于
  • 哥白尼索引
  • 谷歌学术
  • 夏尔巴·罗密欧
  • 打开 J 门
  • Genamics 期刊搜索
  • 中国知网(CNKI)
  • 电子期刊图书馆
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-世界猫
  • SWB 在线目录
  • 虚拟生物学图书馆 (vifabio)
  • 普布隆斯
  • 日内瓦医学教育与研究基金会
  • 欧洲酒吧
  • ICMJE
分享此页面

抽象的

Is Metabolic Syndrome a Risk Factors for Precancerous Colonic Lesions?

Carlo Petruzzellis, Sebastian Manuel Milluzzo, Nicola Petruzzellis, Pietro Cesari

Introduction: Metabolic syndrome (MS) is considered a possible risk factor for CRC, also because it affects bowel cleansing. As primary aim, association between MS or each parameter of MS and the prevalence and histology of precancerous colonic lesions (PCL) was examined. The secondary aim was to analyze the impact of these on bowel cleansing. precancerous colonic lesions (PCL) were examined.

Methods: In this observational single-center study, all consecutive outpatients, who underwent colonoscopy from May to September 2014, were enrolled. For statistical analysis, patients were collapsed into two groups according to the presence or absence of MS.

Results: 1257 patients were enrolled. MS was a risk factor for serrated lesions in the left colon (3% vs 1.2%; p=0.049). Analyzing MS parameters, only a higher BMI was associated with an increased risk of having an adenoma overall (25% for BMI >30), for colonic lesions in the left colon (RR 30%; p<0.01) and only for adenoma in the right colon (RR 30%; p<0.05). MS was inversely related with bowel cleansing overall and per-segments.

Conclusion: The presence of MS and obesity should be taken into consideration prescribing bowel preparation regimen and also for post-polypectomy surveillance, as these elements should be considered as aggravating cancer risk.

免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证。